Literature DB >> 10854206

Association of active extracellular signal-regulated protein kinase with paired helical filaments of inclusion-body myositis muscle suggests its role in inclusion-body myositis tau phosphorylation.

G M Wilczynski1, W K Engel, V Askanas.   

Abstract

The possible role of extracellular signal-regulated kinase (ERK) in the pathogenesis of inclusion-body myositis (IBM) was investigated by immunostaining the active phosphorylated form of ERK in muscle biopsies of six IBM and 14 control patients. Between 80% and 90% of IBM vacuolated muscle fibers contained well-defined ERK-immunoreactive inclusions, which were co-localized by light microscopy, with phosphorylated tau in 70 to 80% of those fibers. Immunoelectronmicroscopy colocalized ERK to small amorphous tufts adjacent to the muscle fiber paired-helical filaments. Strong ERK immunoreactivity was also present at the postsynaptic domain of all human neuromuscular junctions. Our study suggests 1) that ERK, a signal transducer, might play a role in IBM pathogenesis, including participation in the pathological phosphorylation of IBM tau; and 2) that signal transduction abnormalities may be a component of the IBM pathogenic cascade. Our novel immunolocalization of ERK at the postsynaptic domain of human neuromuscular junctions supports a role in transcription of junctional-protein genes. The ERK localized in nonjunctional regions of IBM fibers may underlie the known pathological up-regulation of junctional proteins there.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10854206      PMCID: PMC1850072          DOI: 10.1016/S0002-9440(10)65056-0

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  25 in total

Review 1.  The role of oxidative stress in Alzheimer disease.

Authors:  W R Markesbery
Journal:  Arch Neurol       Date:  1999-12

2.  Recognition of Alzheimer paired helical filaments by monoclonal neurofilament antibodies is due to crossreaction with tau protein.

Authors:  N Nukina; K S Kosik; D J Selkoe
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

3.  Demonstration by fluorescence resonance energy transfer of a close association between activated MAP kinase and neurofibrillary tangles: implications for MAP kinase activation in Alzheimer disease.

Authors:  R B Knowles; J Chin; C T Ruff; B T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  1999-10       Impact factor: 3.685

4.  Twisted tubulofilaments of inclusion body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau.

Authors:  V Askanas; W K Engel; M Bilak; R B Alvarez; D J Selkoe
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

5.  beta-Amyloid precursor epitopes in muscle fibers of inclusion body myositis.

Authors:  V Askanas; R B Alvarez; W K Engel
Journal:  Ann Neurol       Date:  1993-10       Impact factor: 10.422

6.  beta-Amyloid precursor protein mRNA is increased in inclusion-body myositis muscle.

Authors:  E Sarkozi; V Askanas; S A Johnson; W K Engel; R B Alvarez
Journal:  Neuroreport       Date:  1993-06       Impact factor: 1.837

7.  Phosphorylation-dependent epitopes of neurofilament antibodies on tau protein and relationship with Alzheimer tau.

Authors:  B Lichtenberg-Kraag; E M Mandelkow; J Biernat; B Steiner; C Schröter; N Gustke; H E Meyer; E Mandelkow
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

8.  Prion protein is abnormally accumulated in inclusion-body myositis.

Authors:  V Askanas; M Bilak; W K Engel; R B Alvarez; F Tomé; A Leclerc
Journal:  Neuroreport       Date:  1993-10-25       Impact factor: 1.837

9.  Recognition of tau epitopes by anti-neurofilament antibodies that bind to Alzheimer neurofibrillary tangles.

Authors:  H Ksiezak-Reding; D W Dickson; P Davies; S H Yen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

10.  Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state.

Authors:  G Drewes; B Lichtenberg-Kraag; F Döring; E M Mandelkow; J Biernat; J Goris; M Dorée; E Mandelkow
Journal:  EMBO J       Date:  1992-06       Impact factor: 11.598

View more
  8 in total

1.  Casein kinase 1 alpha associates with the tau-bearing lesions of inclusion body myositis.

Authors:  Theresa J Kannanayakal; Jerry R Mendell; Jeff Kuret
Journal:  Neurosci Lett       Date:  2007-12-15       Impact factor: 3.046

Review 2.  Inclusion body myositis: a view from the Caenorhabditis elegans muscle.

Authors:  Daniela L Rebolledo; Alicia N Minniti; Paula M Grez; Ricardo Fadic; Rebecca Kohn; Nibaldo C Inestrosa
Journal:  Mol Neurobiol       Date:  2008-09-05       Impact factor: 5.590

Review 3.  Newest pathogenetic considerations in inclusion-body myositis: possible role of amyloid-beta, cholesterol, relation to aging and to Alzheimer's disease.

Authors:  Valerie Askanas; W King Engel
Journal:  Curr Rheumatol Rep       Date:  2002-10       Impact factor: 4.592

Review 4.  Updates on the Immunopathology in Idiopathic Inflammatory Myopathies.

Authors:  Akinori Uruha; Hans-Hilmar Goebel; Werner Stenzel
Journal:  Curr Rheumatol Rep       Date:  2021-07-01       Impact factor: 4.592

Review 5.  Perturbed signal transduction in neurodegenerative disorders involving aberrant protein aggregation.

Authors:  Mark P Mattson; Michael Sherman
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

6.  IL-1β-Induced Accumulation of Amyloid: Macroautophagy in Skeletal Muscle Depends on ERK.

Authors:  Karsten Schmidt; Magdalena Wienken; Christian W Keller; Peter Balcarek; Christian Münz; Jens Schmidt
Journal:  Mediators Inflamm       Date:  2017-01-12       Impact factor: 4.711

Review 7.  Immune and myodegenerative pathomechanisms in inclusion body myositis.

Authors:  Christian W Keller; Jens Schmidt; Jan D Lünemann
Journal:  Ann Clin Transl Neurol       Date:  2017-05-16       Impact factor: 4.511

8.  How citation distortions create unfounded authority: analysis of a citation network.

Authors:  Steven A Greenberg
Journal:  BMJ       Date:  2009-07-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.